IncFact
Company Profiles: Revenue, Growth, Competition

BIOGEN Revenue, Growth & Competitor Profile

DBA BIOGEN IDEC INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Biogen

Access the complete profile.

Biogen Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
Address225 Binney Street
Cambridge, MA 02142

www.biogenidec.com


Biogen's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Biogen's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Biogen is a publicly traded company on NMS using the ticker symbol BIIB. Detailed information on company financials and operating reports can be found here: NMS: BIIB



Biogen Annual Revenue and Growth Rate

Biogen Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Biogen's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Biogen is developing and marketing. Biogen doesn't have any recent trademark applications, indicating Biogen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
BIOGEN IDEC
providing assistance to patients in obtaining reimbursements from insurers of health care costs
10/23/2003
CERTINJECT
Pharmaceutical preparations for use in the treatment of neurologic disorders
03/12/2003
INVISIJECT
Pharmaceutical preparations for use in the treatment of neurologic disorders
03/03/2003

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Biogen grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Biogen is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Biogen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biogen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
TMUNITY THERAPEUTICSPhiladelphia, PA56 




Nearby Competitors

These companies are similar in business line and location to Biogen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BIOGENCambridge, MA100 
SAREPTA THERAPEUTICSCambridge, MA2 
ABCAMCambridge, MA2 
BRAINTREE LABORATORIESBraintree, MA1 
FOGHORN THERAPEUTICSCambridge, MA1 
RUBIUS THERAPEUTICSCambridge, MA1 




Future Competition: Biogen's Fastest Growing Competitors

These companies are in the same general field as Biogen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Biogen Competitors